Non-invasive Prenatal Testing (NIPT) Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments and Consumables & Reagents), By Technology (Next Generation Sequencing (NGS), Microarray, Polymerase Chain Reaction (PCR), and Rolling Circular Amplification), By End-User (Hospitals and Clinical Laboratories), and Regional Forecast, 2023-2030

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 17.8% from 2023-2030

Unit

Value (USD billion)

Segmentation

By Product, Technology, End User, and Region

By Product

• Consumables & Reagents
• Instruments

By Technology

• Next Generation Sequencing (NGS)
• Microarray
• Polymerase Chain Reaction (PCR)
• Rolling Circular Amplification

By End User

• Hospitals
• Clinical Laboratories

By Region

• North America (By Product, By Technology, By End User, and By Country)
• U.S. (By Product)
• Canada (By Product)
• Europe (By Product, By Technology, By End User, and By Country)
• U.K. (By Product)
• Germany (By Product)
• France (By Product)
• Italy (By Product)
• Spain (By Product)
• Rest of Europe (By Product)

• Asia Pacific (By Product, By Technology, By End User, and By Country)

• China (By Product)
• Japan (By Product)
• India (By Product)
• Australia (By Product)
• Southeast Asia (By Product)
• Rest of Asia Pacific (By Product)
• Latin America (By Product, By Technology, By End User, and By Country)
• Brazil (By Product)
• Mexico (By Product)
• Rest of Latin America (By Product)
• Middle East & Africa (By Product, By Technology, By End User, and By Country)
• GCC (By Product)
• South Africa (By Product)
• Rest of Middle East & Africa (By Product)